Fluoxetine
DrugBank ID: DB00472
Summary
| Metric | Value |
|---|---|
| Total Predictions | 51 |
| KG+DL (Dual Validated) | 5 |
| DL Only | 45 |
| KG Only | 1 |
Predictions
| Indication | Score | Source |
|---|---|---|
| obsessive-compulsive disorder | 0.9996 | KG+DL |
| anxiety disorder | 0.9994 | DL |
| histrionic personality disorder (disease) | 0.9992 | DL |
| paranoid personality disorder | 0.9992 | DL |
| schizoid personality disorder | 0.9992 | DL |
| schizotypal personality disorder | 0.9992 | DL |
| benign paroxysmal torticollis of infancy | 0.9989 | DL |
| endogenous depression | 0.9987 | KG+DL |
| agoraphobia | 0.9986 | DL |
| dysthymic disorder | 0.9983 | KG+DL |
| major depressive disorder | 0.9975 | KG+DL |
| manic bipolar affective disorder | 0.9964 | DL |
| phobic disorder | 0.9963 | DL |
| Ohdo syndrome and variants | 0.9963 | DL |
| unipolar depression | 0.9958 | DL |
| melancholia | 0.9957 | DL |
| neurotic depression | 0.9957 | DL |
| blepharophimosis - intellectual disability syndrome, Ohdo type | 0.9951 | DL |
| dependent personality disorder | 0.9943 | DL |
| narcissistic personality disorder | 0.9934 | DL |
| Keppen-Lubinsky syndrome | 0.9930 | DL |
| neurotic disorder | 0.9930 | KG+DL |
| mixed anxiety and depressive disorder | 0.9926 | DL |
| major affective disorder | 0.9925 | DL |
| bipolar disorder | 0.9910 | DL |
| ligneous conjunctivitis | 0.9907 | DL |
| avoidant personality disorder | 0.9901 | DL |
| post-traumatic stress disorder | 0.9899 | DL |
| congenital isolated adrenocorticotropic hormone deficiency (disease) | 0.9899 | DL |
| autosomal dominant slowed nerve conduction velocity | 0.9880 | DL |
| myofascial pain syndrome | 0.9877 | DL |
| vitamin B12-responsive methylmalonic acidemia | 0.9874 | DL |
| childhood apraxia of speech | 0.9854 | DL |
| surfactant metabolism dysfunction, pulmonary | 0.9829 | DL |
| trigeminal nerve neoplasm | 0.9772 | DL |
| Malan overgrowth syndrome | 0.9747 | DL |
| attention deficit-hyperactivity disorder | 0.9713 | DL |
| distal 17p13.3 microdeletion syndrome | 0.9708 | DL |
| chondromyxoid fibroma | 0.9697 | DL |
| chromosome 15q26-qter deletion syndrome | 0.9668 | DL |
| asperger syndrome, susceptibility to | 0.9654 | DL |
| trichotillomania | 0.9650 | DL |
| autism spectrum disorder | 0.9632 | DL |
| gaze palsy, familial horizontal, with progressive scoliosis | 0.9628 | DL |
| attention deficit hyperactivity disorder, inattentive type | 0.9616 | DL |
| autism susceptibility 1 | 0.9556 | DL |
| chromosome 2P16.3 deletion syndrome | 0.9551 | DL |
| familial hypertryptophanemia | 0.9509 | DL |
| Tourette syndrome | 0.9507 | DL |
| faciodigitogenital syndrome | 0.9495 | DL |
Showing top 50 of 51 predictions.
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.